NovaBay Pharmaceuticals, Inc. 8-K

What Happened
NovaBay Pharmaceuticals, Inc. announced on January 30, 2026 that, with its Audit Committee’s approval, it engaged CBIZ CPAs, P.C. as its new independent registered public accounting firm for the fiscal year ending December 31, 2025. The company also disclosed it will hold a special meeting of stockholders on March 12, 2026 at 11:00 a.m. ET to vote on corporate actions including approval to issue common stock upon exercise of pre-funded warrants issued in private placements on January 16, 2026 and October 16, 2025.

Key Details

• New auditor: CBIZ CPAs, P.C., engaged January 30, 2026 for fiscal year ending Dec 31, 2025.
• No consultations: NovaBay reported no consultations with CBIZ during 2024, 2025 or through Jan 30, 2026 about accounting or auditing matters that would meet Item 304 consultation/disagreement/reportable event definitions.
• Special meeting: Scheduled for March 12, 2026 at 11:00 a.m. ET; record date for solicitation is February 10, 2026.
• Proxy materials: Preliminary Proxy Statement filed; Definitive Proxy Statement and related materials to be mailed beginning on or about February 13, 2026.

Why It Matters
A change in independent auditor is material because it affects who audits NovaBay’s financial statements and may be of interest to investors monitoring financial reporting quality. The special meeting vote on issuing shares for pre-funded warrants could affect share count and dilution if approved, so stockholders should review the proxy materials (filed with the SEC) before voting.